Australia
Charles Fridlender
CEO & Director
Tim Dean
CFO & Director
Andrew Mendelawitz
Director of Commercial
Extensive track-record as technical consultant to pharma companies.
Developer of range of OTC and Rx pharma, device and drugs. Former Director of Komipharm International Australia and NS Technologies. Global network in pharma manufacturing equipment & marketing.
Fmr. International Business Development Manager. CSL Limited Managing Director, Pharmamed International. Former General Manager and Group Financial Controller, Sypharma Pty Ltd, Director of International Sales, Seasol.
Twenty years experience in investor relations, corporate affairs and as a Non-Executive Director with ASX, TSX-V, and CSE companies. Honorary Consul to Guatemala and Secretary of the Consular Corps of Melbourne.
_jfif.jpg)
Dr Diviang Butala
Processing and Formulation
Prof. Dr Fiona Wood AO
Medical Advisor
Plastic Surgery
Prof. Bruce Sunderland
Pharmacology Advisor
Over 25 years’ experience in Product Development , Project Management, Technology Transfer & manufacturing, Regulatory Affairs, QC, Laboratory Development Management, CRO auditing. Performing eGMP, IQ, OQ,PQ, CAPA,OOS, CMC section for regulatory submission to TGA, EU and US FDA.
Director of the Royal Perth Hospital burns unit and the Western Australia Burns Service. Famous for revolutionary “spray on skin” and work during the Bali bombing. Clinical Professor with the School of Paediatrics and Child Health at the University of Western Australia.Director of the McComb Research Foundation
Head of School of Pharmacy at Curtin University (Perth) for more than 20 years. Published more than 200 peer-reviewed scientific publications and has worked as a consultant for pharma companies for more than 30 years.
Israel
Mr Buchta has 25+ years managing and leading companies and research groups focused on innovation in new product development R&D, Manufacturing, Operations and Business Development leading 150+ product developments with 75+ launched to date, and achieving accumulated sales of $2.0 B
Dr. Yona Nadir, MD, Ph.D. is a Professor at the Department of Hematology and the Director of the Blood Clotting Unit & Principal Investigator at the Nadir Lab, Thrombosis & Haemostasis Unit, at the Rambam Health Care Campus, Haifa, Israel.
Expert with Medical and Commercial aspects in Asia & Pacific Markets. Former Director Asia & Pacific - Teva Pharmaceuticals. Senior Director, Commercial Operation TAPI - Asia. CEO Light Rail Transit, Jerusalem. Senior Director - Hornet Medical Devices.
Dr Richard Buchta
Director of Israel
Dr Yona Nadir
Scientific Director Rambam Medtech
Yehuda Shoshani
Advisor Israel
Global
Prof. Dr Fiona Wood AO
Medical Advisor
- Plastic Surgery
Prof. Bruce Sunderland
Pharmacology Advisor
Prof. Stephan Schug
Anaesthesia & Pain Medicine Advisor
Dr. Stephanie Parker
Medical & Clinical Advisor
Gary Bird
Sales & Marketing Advisor
Asia Pacific
Dr Lourdes Santiso
Paediatric Plastic Surgeon
Guatemala City
Fmr. Asia Pacific Marketing Director, Pain Management, Johnson & Johnson
Managing Director Medreich Australia; MD Croma-Pharma; Country Manager Medis. Senior experience in manufacturing, OTC/retail pharmacy, prescription medicines & medical devices
Chief of paediatric plastic surgery at Nino Sano and Hospital Roosevelt, Guatemala City. Extensive experience using Pharmachal's NOPAYNE lidocaine spray since the 2018 volcanic mass-casualty disaster.